# Zhiyong Peng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zhiyong-peng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,064 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 24 |
| i10-index | 44 |
| Last Known Institution | Xiangtan University |
| OpenAlex ID | https://openalex.org/A5030775865 |
| ORCID iD | 0000-0002-0849-5648 |
| Works | 120 |

## Researcher papers

- [A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)](https://scholariq.org/papers/a-rapid-advice-guideline-for-the-diagnosis-and-treatment-of-2019-novel/)
- [Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China](https://scholariq.org/papers/clinical-features-and-short-term-outcomes-of-221-patients-with-covid-19-in-wuhan/)
- [Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial](https://scholariq.org/papers/rezafungin-versus-caspofungin-for-treatment-of-candidaemia-and-invasive/)
- [Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2](https://scholariq.org/papers/exosomal-mir-25-3p-from-mesenchymal-stem-cells-alleviates-myocardial-infarction/)
- [Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial](https://scholariq.org/papers/intravenous-high-dose-vitamin-c-for-the-treatment-of-severe-covid-19-study/)
- [Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)](https://scholariq.org/papers/chemoprophylaxis-diagnosis-treatments-and-discharge-management-of-covid-19-an/)
- [Downregulation of exosome‐encapsulated miR‐548c‐5p is associated with poor prognosis in colorectal cancer](https://scholariq.org/papers/downregulation-of-exosome-encapsulated-mir-548c-5p-is-associated-with-poor/)
- [Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI](https://scholariq.org/papers/downregulation-of-macrophage-migration-inhibitory-factor-attenuates-nlrp3/)
- [Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China](https://scholariq.org/papers/clinical-features-and-outcomes-of-221-patients-with-covid-19-in-wuhan-china/)
- [The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community‐acquired pneumonia](https://scholariq.org/papers/the-influence-of-macrophage-migration-inhibitory-factor-gene-polymorphisms-on/)
- [Causes and predictors of mortality from lupus nephritis in Southern Hunan, China](https://scholariq.org/papers/causes-and-predictors-of-mortality-from-lupus-nephritis-in-southern-hunan-china/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)

## Researcher university

- [Xiangtan University](https://scholariq.org/institutions/xiangtan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.